Delivery Order SPE2DB22D3501-SPE2DB24FVR15
- Not listed
- The U.S. Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract worth $2,374.92 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4564782841 CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product, with a period of performance through June 4, 2024. This delivery order is made under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,348.12 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564415606 Cefazolin 2 g/50 mL-Dextroses. This contract has an ultimate completion date of April 29, 2024 and is not set aside. Amerisourcebergen Drug Corp, through its Corporate Office Division, is a major pharmaceutical distributor for the U.S. federal government, particularly for the Department...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,583.28 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division to supply 4564479600 units of the pharmaceutical product Cefazolin 2 G/50 ML-Dextroses. This contract does not have a set-aside designation and has an ultimate completion date of May 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Cefazolin 2 g/50 ml-dextrose medical supplies. The order has a potential value of $1,583.28 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which is not set aside under any special program....
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $15,866.68 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, with a period of performance through June 10, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC serves...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,715.76. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a key customer for Amerisourcebergen. The award is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a critical medical product, with an ultimate completion date of August 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of pharmaceutical products and medical supplies. The $2,457.54 firm fixed-price contract has an ultimate completion date of April 26, 2024. Amerisourcebergen has a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a comprehensive range of medications...
- This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6DBL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a $2,167.92 Firm Fixed Price Delivery Order for the supply of 4,566,383,974 units of Cefazolin 2 G/50 ML-Dextroses, a pharmaceutical product. The contract has an ultimate completion date of November 12, 2024 and was awarded on November 8, 2024. Amerisourcebergen Drug Corp is a major...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,882.49 firm fixed-price delivery order is for the supply of Cefazolin 2 G/50 ML-Dextrose, a pharmaceutical product. The award has an ultimate completion date of April 1, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The U.S. government awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the provision of pharmaceutical products and medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $5,678.04 and an ultimate completion date of August 14, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 31,...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FVR15Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,374.92 firm fixed price contract is for the supply of the pharmaceutical product Cefazolin 2 g/50 ml-dextrose. The contract has an ultimate completion date of May 15, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 2025. This single-award IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 5/14/24 |